CytoMed Therapeutics Ltd (GDTC)
2.24
+0.02
(+0.90%)
USD |
NASDAQ |
Nov 14, 16:00
2.24
0.00 (0.00%)
After-Hours: 18:44
CytoMed Therapeutics Shareholders Equity (Quarterly): 7.489M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 7.489M |
| June 30, 2024 | 7.489M |
| December 31, 2023 | 8.514M |
| June 30, 2023 | 9.710M |
| June 30, 2023 | 9.710M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.4377M |
| June 30, 2022 | 1.120M |
| June 30, 2022 | 1.120M |
| December 31, 2021 | 1.917M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.4377M
Minimum
Dec 2022
9.710M
Maximum
Jun 2023
5.278M
Average
7.489M
Median
Jun 2024
Shareholders Equity (Quarterly) Benchmarks
| EUDA Health Holdings Ltd | -6.023M |
| Raffles Medical Group Ltd | 748.94M |
| Haw Par Corp Ltd | 2.724B |
| WAVE Life Sciences Ltd | -3.477M |
| Mobile-health Network Solutions | 4.140M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.040M |
| Total Liabilities (Quarterly) | 0.5518M |